Skip to main content
Top
Published in: Gastric Cancer 4/2011

Open Access 01-10-2011 | Special Article

Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry

Authors: Yoh Isobe, Atsushi Nashimoto, Kohei Akazawa, Ichiro Oda, Kenichi Hayashi, Isao Miyashiro, Hitoshi Katai, Shunichi Tsujitani, Yasuhiro Kodera, Yasuyuki Seto, Michio Kaminishi

Published in: Gastric Cancer | Issue 4/2011

Login to get access

Abstract

The Japanese Gastric Cancer Association (JGCA) started a new nationwide gastric cancer registry in 2008. Approximately 50 data items, including surgical procedures, pathological diagnoses, and survival outcomes, for 12004 patients with primary gastric cancer treated in 2001 were collected retrospectively from 187 participating hospitals. Data were entered into the JGCA database according to the JGCA Classification of gastric carcinoma, 13th edition and the International Union Against Cancer (UICC) TNM Classification of malignant tumors, 5th edition by using an electronic data collecting system. Finally, data of 11261 patients with gastric resection were analyzed. The 5-year follow-up rate was 83.5%. The direct death rate was 0.6%. TNM 5-year survival rates (5YSRs)/JGCA 5YSRs were 91.8/91.9% for stage IA, 84.6/85.1% for stage IB, 70.5/73.1% for stage II, 46.6/51.0% for stage IIIA, 29.9/33.4% for stage IIIB, and 16.6/15.8% for stage IV. The proportion of patients more than 80 years old was 7.0%, and their 5YSR was 48.7%. Compared to the JGCA archived data, though the follow-up rate needs to be improved, these data suggest that the postoperative results of patients with primary gastric carcinoma have improved in those with advanced disease and in the aged population in Japan.
Appendix
Available only for authorised users
Literature
1.
go back to reference Maruyama K, Kaminishi M, Hayashi K, Isobe Y, Honda I, Katai H, et al. Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry. Gastric Cancer. 2006;9:21–66. Maruyama K, Kaminishi M, Hayashi K, Isobe Y, Honda I, Katai H, et al. Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry. Gastric Cancer. 2006;9:21–66.
2.
go back to reference Nashimoto A, Akazawa K, Isobe Y, Miyashiro I, Oda I, Kaminishi M, et al. The present state and problems of gastric cancer treatment from the view points of nationwide registry. Jpn J Cancer Clin. 2009;55:713–8 (in Japanese). Nashimoto A, Akazawa K, Isobe Y, Miyashiro I, Oda I, Kaminishi M, et al. The present state and problems of gastric cancer treatment from the view points of nationwide registry. Jpn J Cancer Clin. 2009;55:713–8 (in Japanese).
3.
go back to reference Isobe Y, Nashimoto A, Akazawa K, Hayashi K, Miyashiro I, Oda I, et al. Problems and future perspectives on the nationwide registry of gastric cancer. Gekachiryo. 2010;102:358–64 (in Japanese). Isobe Y, Nashimoto A, Akazawa K, Hayashi K, Miyashiro I, Oda I, et al. Problems and future perspectives on the nationwide registry of gastric cancer. Gekachiryo. 2010;102:358–64 (in Japanese).
4.
go back to reference Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. 13 ed. Tokyo: Kanehara; 1999 (in Japanese). Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. 13 ed. Tokyo: Kanehara; 1999 (in Japanese).
5.
go back to reference Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma—2nd English edition. Gastric Cancer. 1998;1:10–24.CrossRefPubMed Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma—2nd English edition. Gastric Cancer. 1998;1:10–24.CrossRefPubMed
6.
go back to reference International Union Against Cancer. Sobin LH, Wittekind C, editors. TNM classification of malignant tumors. 5th ed. New York: WILEY-LISS; 1997. International Union Against Cancer. Sobin LH, Wittekind C, editors. TNM classification of malignant tumors. 5th ed. New York: WILEY-LISS; 1997.
7.
go back to reference Japanese Gastric Cancer Association. Gastric cancer treatment guidelines for doctors’ reference. Tokyo: Kanehara; 2001 (in Japanese). Japanese Gastric Cancer Association. Gastric cancer treatment guidelines for doctors’ reference. Tokyo: Kanehara; 2001 (in Japanese).
9.
go back to reference Marugame T, Matsuda T, Kamo K, Katanoda K, Ajiki W, Sobue T, et al. Cancer incidence and incidence rates in Japan in 2001 based on the data from 10 population-based cancer registries. Jpn J Clin Oncol. 2007;37:884–91.CrossRefPubMed Marugame T, Matsuda T, Kamo K, Katanoda K, Ajiki W, Sobue T, et al. Cancer incidence and incidence rates in Japan in 2001 based on the data from 10 population-based cancer registries. Jpn J Clin Oncol. 2007;37:884–91.CrossRefPubMed
10.
go back to reference Survival rate in the member hospitals of the Association of Clinical Cancer Centers (diagnosed in 1997–2000). In: Kato H, Sobue T, Katanoda K, Saito Y, Tukuma H, Saruki N, et al., editors. Cancer statistics in Japan—2008. Tokyo: Foundation for Promotion of Cancer Research; 2009. p. 81. Survival rate in the member hospitals of the Association of Clinical Cancer Centers (diagnosed in 1997–2000). In: Kato H, Sobue T, Katanoda K, Saito Y, Tukuma H, Saruki N, et al., editors. Cancer statistics in Japan—2008. Tokyo: Foundation for Promotion of Cancer Research; 2009. p. 81.
Metadata
Title
Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry
Authors
Yoh Isobe
Atsushi Nashimoto
Kohei Akazawa
Ichiro Oda
Kenichi Hayashi
Isao Miyashiro
Hitoshi Katai
Shunichi Tsujitani
Yasuhiro Kodera
Yasuyuki Seto
Michio Kaminishi
Publication date
01-10-2011
Publisher
Springer Japan
Published in
Gastric Cancer / Issue 4/2011
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-011-0085-6

Other articles of this Issue 4/2011

Gastric Cancer 4/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.